pravastatin has been researched along with Bronchiolitis, Exudative in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barry, EV; Duncan, CN; Lehmann, LE | 1 |
| Gottlieb, J; Haverich, A; Kuehn, C; Li, Y; Ma, D; Simon, AR; Strueber, M; Warnecke, G; Welte, T | 1 |
2 other study(ies) available for pravastatin and Bronchiolitis, Exudative
| Article | Year |
|---|---|
Tolerability of pravastatin in pediatric hematopoietic stem cell transplant patients with bronchiolitis obliterans.
Topics: Adolescent; Alanine Transaminase; Anticholesteremic Agents; Bronchiolitis Obliterans; Child; Creatine Kinase; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Maximum Tolerated Dose; Pilot Projects; Pravastatin; Treatment Outcome | 2010 |
Graft-protective effects of the HMG-CoA reductase inhibitor pravastatin after lung transplantation--a propensity score analysis with 23 years of follow-up.
Topics: Adult; Bronchiolitis Obliterans; Female; Follow-Up Studies; Graft Survival; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kaplan-Meier Estimate; Lung Transplantation; Male; Middle Aged; Pravastatin; Proportional Hazards Models; Retrospective Studies; Vital Capacity | 2011 |